You are here


  • Cancer cachexia: mechanisms and progress in treatment

    cancer_cachexia_book_cover_newEgidio Del Fabbro, Kenneth Fearon† and Florian Strasser

    Cancer cachexia – a multifactorial syndrome characterized by a significant reduction in body weight associated with reduced muscle mass and adipose tissue – affects up to 80% of patients with advanced cancer. It is a very serious complication of cancer, associated with more chemotherapy-related side effects, fewer completed cycles of chemotherapy, reduced quality of life and decreased survival rates. Cancer cachexia is often under-recognized, being perceived as unavoidably linked with disease progression.

  • Prevention of nausea and vomiting in adult cancer patients receiving tumour-directed therapy – 2017 update –

    Nausea book coverMatti Aapro, Karin Jordan and Petra Feyer

    Irrespective of the timing of their onset – acute, delayed or anticipatory – and of the underlying causative mechanisms, cancer treatment-induced nausea and vomiting represent an important burden on the quality of life for cancer patients. Prevention of these sequelae is therefore an essential component of supportive care in cancer, helping patients to better accept and tolerate their anti-neoplastic treatment and related emetic side effects.

Search this site

Featured videos

Free access to ebooks on cachexia and CINV


Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

Cancer cachexia: mechanisms and progress in treatment


Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo